Chronic prostatitis(qi stagnant and blood stasis)
Conditions
Interventions
CP1 group:Oral CP1 square decoction granules
Prostasin capsule group:Oral Qianliexin Jiaonang
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the diagnostic criteria of Western medicine for type III prostatitis (2) Patients with moderate to severe NIH-CPSI score (moderate patient score: 15<= NIH-CPSI <= 29 points; Severe patient score: 30<=NIH-CPSI 43 points) (3) Those who meet the differentiation of qi stagnation and blood stasis (4) The course of the disease is more than 3 months (5) Age 18~50 years old (6) Patients who have been treated before the visit can be included in the study after stopping the drug for at least 2 weeks=
Exclusion criteria
Exclusion criteria: (1) Patients with prostate tumors, neurogenic bladder dysfunction, urethral malformations or strictures, and severe neuroses (2) Patients with urinary tract infection and urethritis (3) Those with local pain as the main manifestation should exclude other diseases of the lower abdomen, perineum, lumbosacral and other parts, such as ureters, bladder stones, inguinal hernia, pubitis, varicocele, epididymitis, proctocolic disease, low back myofasciitis, etc (4) Complicated with cardiovascular and cerebrovascular, liver, kidney and hematopoietic system serious primary diseases; (5) The subject is participating in other drug clinical trials at the same time or is using drugs with similar therapeutic effects to the experimental drug (6) The subjects are unwilling to participate in the trial or do not cooperate with the treatment (7) Those who are not considered suitable to participate in clinical trials by the investigator (8) In the process of participating in this trial, patients used Chinese and Western medicines, health care products and Chinese medicine decoctions containing prescription pieces that have therapeutic effects on the disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| National Institutes of Health Chronic Prostatitis Symptom Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM certificate score; | — |
Countries
China
Contacts
Public ContactWang Bin
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed